0001012975-15-000065.txt : 20150126
0001012975-15-000065.hdr.sgml : 20150126
20150126160711
ACCESSION NUMBER: 0001012975-15-000065
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20141231
FILED AS OF DATE: 20150126
DATE AS OF CHANGE: 20150126
EFFECTIVENESS DATE: 20150126
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Third Rock Ventures, LLC
CENTRAL INDEX KEY: 0001600135
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16025
FILM NUMBER: 15548636
BUSINESS ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001600135
XXXXXXXX
12-31-2014
12-31-2014
Third Rock Ventures, LLC
29 NEWBURY STREET
3RD FLOOR
BOSTON
MA
02116
13F HOLDINGS REPORT
028-16025
N
Kevin Gillis
Chief Financial Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
01-26-2015
0
6
1222711
false
INFORMATION TABLE
2
trv.xml
Agios Pharmaceuticals, Inc.
COM
00847X104
343973
3070090
SH
DFND
3070090
0
0
bluebird bio, Inc.
COM
09609G100
111445
1215054
SH
DFND
1215054
0
0
Eleven Biotherapeutics, Inc.
COM
286221106
57518
4841591
SH
DFND
4841591
0
0
Foundation Medicine, Inc.
COM
350465100
109483
4927234
SH
DFND
4927234
0
0
Sage Therapeutics, Inc.
COM
78667J108
427525
11681008
SH
DFND
11681008
0
0
Zafgen Inc.
COM
98885E103
172767
5602045
SH
DFND
5602045
0
0